Crinetics Pharmaceuticals Inc (CRNX)
42.98
-0.01
(-0.02%)
USD |
NASDAQ |
Apr 19, 16:00
42.98
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Market Cap: 3.349B for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 3.350B |
| April 17, 2024 | 3.430B |
| April 16, 2024 | 3.389B |
| April 15, 2024 | 3.404B |
| April 12, 2024 | 3.475B |
| April 11, 2024 | 3.743B |
| April 10, 2024 | 3.577B |
| April 09, 2024 | 3.656B |
| April 08, 2024 | 3.619B |
| April 05, 2024 | 3.704B |
| April 04, 2024 | 3.635B |
| April 03, 2024 | 3.711B |
| April 02, 2024 | 3.585B |
| April 01, 2024 | 3.626B |
| March 28, 2024 | 3.648B |
| March 27, 2024 | 3.462B |
| March 26, 2024 | 3.380B |
| March 25, 2024 | 3.360B |
| March 22, 2024 | 3.451B |
| March 21, 2024 | 3.504B |
| March 20, 2024 | 3.545B |
| March 19, 2024 | 3.521B |
| March 18, 2024 | 2.956B |
| March 15, 2024 | 3.034B |
| March 14, 2024 | 2.978B |
| Date | Value |
|---|---|
| March 13, 2024 | 3.156B |
| March 12, 2024 | 3.176B |
| March 11, 2024 | 3.240B |
| March 08, 2024 | 3.296B |
| March 07, 2024 | 3.312B |
| March 06, 2024 | 3.391B |
| March 05, 2024 | 3.346B |
| March 04, 2024 | 3.391B |
| March 01, 2024 | 3.587B |
| February 29, 2024 | 2.849B |
| February 28, 2024 | 2.976B |
| February 27, 2024 | 2.817B |
| February 26, 2024 | 2.691B |
| February 23, 2024 | 2.565B |
| February 22, 2024 | 2.556B |
| February 21, 2024 | 2.533B |
| February 20, 2024 | 2.604B |
| February 16, 2024 | 2.578B |
| February 15, 2024 | 2.517B |
| February 14, 2024 | 2.475B |
| February 13, 2024 | 2.454B |
| February 12, 2024 | 2.679B |
| February 09, 2024 | 2.690B |
| February 08, 2024 | 2.622B |
| February 07, 2024 | 2.576B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
283.01M
Minimum
Mar 16 2020
3.743B
Maximum
Apr 11 2024
971.51M
Average
857.90M
Median
Apr 06 2023
Market Cap Benchmarks
| Catalyst Pharmaceuticals Inc | 1.782B |
| Geron Corp | 2.018B |
| Madrigal Pharmaceuticals Inc | 4.220B |
| PTC Therapeutics Inc | 1.944B |
| Syndax Pharmaceuticals Inc | 1.768B |
Market Cap Related Metrics
| PS Ratio | 528.53 |
| PEG Ratio | -0.5535 |
| Price to Book Value | 6.213 |
| Price | 42.98 |
| Earnings Yield | -8.61% |
| PEGY Ratio | -0.5535 |